Premium – Page 3 – Endpoints News

SIGN UP

#ASH22 Recap: Leading hematology experts talk top readouts; Fireside chat with Novo Nordisk's Ludovic Helfgott; More

Last month

Scoop: As Sio closes, former CEO from ‘vant exit finds himself at helm of Irv Weissman stealth biotech

Last month

Scoop: Moderna co-founder's regenerative medicine biotech nabs funds, but loses Genentech

Last month

Debating the p-values behind Moderna's $16B market-cap gain

Last month

Scoop: Blade Therapeutics CEO, CFO appear to depart amid 'transition' after nixed SPAC

Last month

Scoop: Stephen Squinto’s Yale spinout is raising a Series B for genetic medicines

2 months ago

Scoop: Oncopeptides CEO ‘leaning toward’ giving in to FDA withdrawal request amid ‘pissing contest’ with regulators

2 months ago

Vertex just found the next big ‘transformative’ thing for the pipeline — at a biotech just down the street

2 months ago

Priming therapy biotech emerges from stealth with seed funding — and on a hunt for partners

2 months ago

Q&A: Bristol Myers' Kristen Hege on cell therapy, cancer patients and mentoring the next generation

2 months ago

Scoop: Avalon, MPM back new CNS biotech with scientific chops from Astellas

2 months ago

Gossamer’s Faheem Hasnain defends a round of positive PAH data as a clear win. But can these PhII results stand up to scrutiny?

2 months ago

As money pours into digital therapeutics, insurance coverage crawls

2 months ago

Eisai’s expanded Alzheimer’s data leave open questions about safety and clinical benefit

2 months ago

Allogene takes the stage in New York to go deep on its off-the-shelf cell therapies — declaring a first for solid tumors

2 months ago

Twitter disarray continues as pharma advertisers extend pauses and look around for options, but keep tweeting

2 months ago

Updated: AstraZeneca jumps deeper into cell therapy 2.0 space with $320M biotech M&A

2 months ago

FDA tells Catalent to fix issues at two manufacturing sites on its own

2 months ago

Vaccine documents, young leaders and market turmoil: Endpoints' 10 biggest stories of 2022

2 months ago

Scoop: Versant, NEA launch new biotech helmed by ex-CEO of protein degrader C4 Therapeutics

2 months ago

Twitter advertising pause or persist? Pharmas quietly weigh options in uncertain time

3 months ago

By the numbers: As the pandemic biotech boom fades, it's beginning to look a lot like 2019 — or before

3 months ago

Altos Labs founders Barron and Klausner: 'There are mechanisms in the cell where you can reset not the stress curve, but the resilience curve'

3 months ago

Scoop: A SoftBank-backed biotech raises more funds after bagging $100M+ for fungi mining

3 months ago

First page Previous page 1 234 5 6 Next page Last page